🎁 Black Friday: up to 50% off of annual plans

Charles Moore

Stock Analyst at Robert W. Baird

(0.21)
# 4,768
Out of 5,189 analysts
11
Total ratings
n/a
Success rate
-38%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Charles Moore

Bright Minds Biosciences
Nov 3, 2026
Reiterated: Buy
Price Target: $126 → $107
Current: $20.40
Upside: +424.51%
Contineum Therapeutics
Oct 14, 2026
Downgraded: Hold
Price Target: $19 → $14
Current: $8.68
Upside: +61.29%
Denali Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $34
Current: $18.45
Upside: +84.28%